Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
87.23
-2.39 (-2.67%)
At close: Nov 6, 2026, 4:00 PM EST
87.77
+0.54 (0.62%)
After-hours: Nov 6, 2026, 5:43 PM EST
Merit Medical Systems Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $107. The average 1-year stock price forecast is 22.66% higher than the current stock price, while the lowest is $90 (+3.18%) and the highest is $123 (+41.01%).
Price Target: $107 (+22.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $114 → $116 | Buy | Maintains | $114 → $116 | +32.98% | Oct 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $95 → $110 | Buy | Reiterates | $95 → $110 | +26.10% | Oct 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $106 → $108 | Buy | Reiterates | $106 → $108 | +23.81% | Oct 30, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Reiterates $83 → $92 | Hold | Reiterates | $83 → $92 | +5.47% | Oct 30, 2026 |
| Needham | Needham | Buy Reiterates $101 → $106 | Buy | Reiterates | $101 → $106 | +21.52% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
1.64B
from 1.52B
Increased by 8.14%
Revenue Next Year
1.74B
from 1.64B
Increased by 6.22%
EPS This Year
4.34
from 3.83
Increased by 13.43%
EPS Next Year
4.65
from 4.34
Increased by 7.03%
EPS and Forward PE are based on non-GAAP adjusted numbers.